Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition.

Saved in:

Bibliographic Details
Title:	Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition.
Authors:	Beaudoin JJ; DILIsym Services Division, Simulations Plus Inc., Research Triangle Park, NC, United States., Yang K; DILIsym Services Division, Simulations Plus Inc., Research Triangle Park, NC, United States., Adiwidjaja J; DILIsym Services Division, Simulations Plus Inc., Research Triangle Park, NC, United States.; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Taneja G; DILIsym Services Division, Simulations Plus Inc., Research Triangle Park, NC, United States., Watkins PB; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Siler SQ; DILIsym Services Division, Simulations Plus Inc., Research Triangle Park, NC, United States., Howell BA; DILIsym Services Division, Simulations Plus Inc., Research Triangle Park, NC, United States., Woodhead JL; DILIsym Services Division, Simulations Plus Inc., Research Triangle Park, NC, United States.
Source:	Frontiers in pharmacology [Front Pharmacol] 2023 Jan 17; Vol. 13, pp. 1085621. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2022).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2022.1085621